Metaceutic ApS: Financial statements 2021
CVR: 40638350
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Metaceutic ApS (CVR 40638350) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -2,188,780 and a net result of DKK -4,185,532. Equity in the 2021 report amounted to DKK 2,066,381. The solvency ratio was 82.8%. The company had 4 employees in the financial year.
- Gross Profit
- DKK -2,188,780
- Profit/Loss
- DKK -4,185,532
- Equity
- DKK 2,066,381
- Total Assets
- DKK 2,495,904
- Employees
- 4
Official annual report
Find more companies like Metaceutic ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
Metaceutic ApS has published its interim report for the period July 4, 2019 – December 31, 2020.
As of May 17, 2021, Ginnerup Capital ApS is registered as an owner of Metaceutic ApS with an ownership share of 5%.
As of May 17, 2021, A. Kazemi ApS is registered as an owner of Metaceutic ApS with an ownership share of 66%.
About Metaceutic ApS
Metaceutic ApS is a Danish company of the type Anpartsselskab based in Herlev, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ali Kazemi Seresht. The company is owned by Ginnerup Capital ApS and A. Kazemi ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,095,622 and a net result of DKK 2,364,576 compared with DKK -1,318,986 the year before. Equity in the 2025 report amounted to DKK 276,791.